Innate Immunity to Pulmonary Infection

Part of the prestigious Novartis Foundation series, this volume uniquely addresses the use of innate immunity to treat or prevent infectious diseases of the lung. <p><b><i>Innate Immunity to Pulmonary Infection:</i></b></p> <ul type=”disc”> <li>Provides a comprehensive overview of pulmonary infectious diseases, including basic pathology, current and potential therapies, and detailed consideration of the innate biological resistance mechanisms in the lung</li> <li>Thoroughly examines the major topic of innate immunity in immunology, which is now seen as key to the pathogenesis of and vaccination strategies for infectious diseases</li> <li>Describes the genetic and environmental factors which determine the outcome of infection, such as latency of Tuberculosis, blood stream invasion from local infection, and local target tissue damage</li> <li>Covers the roles of cells such as neutrophils, macrophages and dendritic cells and of molecular components such as Toll-like receptors</li> <li>Discusses the clinical applications of the new knowledge regarding innate immunity and how this can be used in both treatment and prevention (vaccination) strategies</li> <li>Includes contributions from an international and interdisciplinary group of experts</li> </ul> <p><b><i>Innate Immunity to Pulmonary Infection</i></b> is an essential resource for researchers in both industry and academia. It is of interest for all those interested in the disciplines of immunology, virology, biology, biotechnology and genetics.</p>